Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations. [electronic resource]
Producer: 20180918Description: 395-402 p. digitalISSN:- 1600-0609
- Adolescent
- Adult
- Cyclophosphamide -- therapeutic use
- Female
- Graft Survival
- Graft vs Host Disease -- diagnosis
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Postoperative Care
- Premedication
- Tissue Donors
- Transplantation Conditioning -- adverse effects
- Transplantation, Haploidentical
- Transplantation, Homologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.